Search research articles
Contact Us
Filters
Showing results (191-200 of 215) with videos related to
Page
of 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2004
Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front-line autotransplantation after complete remission: a cohort study by the Groupe d'Etude des Lymphomes de l'Adulte
N Mounier, C Gisselbrecht, J Brière, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2004
All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
N Mounier, C Gisselbrecht, J Brière, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 25, 2002
Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma
T Rüdiger, R D Gascoyne, E S Jaffe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2000
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study
C Haioun, E Lepage, C Gisselbrecht, et al.
Bone Marrow Transplantation
|
July 12, 2005
Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trial
D Valteau-Couanet, C Faucher, A Aupérin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1997
Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte
C Haioun, E Lepage, C Gisselbrecht, et al.
Presse Medicale (Paris, France : 1983)
|
October 16, 1999
[Bone marrow transplantation in the treatment of autoimmune diseases. ISAMAIR Group]
D Farge, M Breban, L Guillevin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte
D Wendum, C Sebban, P Gaulard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial
C Guglielmi, F Gomez, T Philip, et al.
The American Journal of Medicine
|
December 19, 2001
Human immunodeficiency virus-related lymphoma: relation between clinical features and histologic subtypes
J Gabarre, M Raphael, E Lepage, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 215) with videos related to
Sort By:
Page
of 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2004
Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front-line autotransplantation after complete remission: a cohort study by the Groupe d'Etude des Lymphomes de l'Adulte
N Mounier, C Gisselbrecht, J Brière, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2004
All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
N Mounier, C Gisselbrecht, J Brière, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 25, 2002
Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma
T Rüdiger, R D Gascoyne, E S Jaffe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2000
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study
C Haioun, E Lepage, C Gisselbrecht, et al.
Bone Marrow Transplantation
|
July 12, 2005
Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trial
D Valteau-Couanet, C Faucher, A Aupérin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1997
Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte
C Haioun, E Lepage, C Gisselbrecht, et al.
Presse Medicale (Paris, France : 1983)
|
October 16, 1999
[Bone marrow transplantation in the treatment of autoimmune diseases. ISAMAIR Group]
D Farge, M Breban, L Guillevin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte
D Wendum, C Sebban, P Gaulard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial
C Guglielmi, F Gomez, T Philip, et al.
The American Journal of Medicine
|
December 19, 2001
Human immunodeficiency virus-related lymphoma: relation between clinical features and histologic subtypes
J Gabarre, M Raphael, E Lepage, et al.
Page
of 22